{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:19:20Z","timestamp":1775816360955,"version":"3.50.1"},"reference-count":39,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: The accurate evaluation of the fibrosis stage is critical for improving chronic hepatitis B (CHB) management and patient outcomes. This study aimed to compare the diagnostic accuracy of non-invasive fibrosis markers with liver biopsy for detecting significant, advanced fibrosis and cirrhosis. We further investigated the diagnostic performance of non-invasive markers according to HBeAg status to provide further insight into their clinical utility across patient subgroups. Methods: This single-center retrospective study included 536 treatment-naive patients with CHB who underwent liver biopsy. Patients were categorized into four groups according to the fibrosis stage: \u201cno significant fibrosis\u201d (F0\u2013F2), \u201csignificant fibrosis\u201d (F3\u2013F6), \u201cadvanced fibrosis\u201d (F4\u2013F6), and \u201ccirrhosis\u201d (F5\u2013F6). AAR, AAPRI, APRI, API, FIB-4, GPR, and S\u2013index were compared among these groups. Results: In total, 536 treatment-na\u00efve patients were analyzed (63.2% male; mean age 44.8 \u00b1 12.9 years), of whom 25.4% were HBeAg-positive. API, FIB 4, GPR, and S-Index showed good performance (area under the curve [AUC] \u2265 0.8\u20130.9) in defining advanced fibrosis (\u2265F4), AAPRI, AAR, API, and APRI showed good performance ([AUC] &lt; 0.700) in defining cirrhosis. The analysis showed that GPR had the highest AUC for \u2265F3 (0.719) and \u2265F4 (0.838), while FIB 4 had the highest AUC for cirrhosis (0.865). Conclusions: These findings highlight the value of non-invasive markers as inexpensive and easily applicable methods for clinicians in assessing the stage of liver fibrosis. The integration of these scores into the routine monitoring of chronic hepatitis B patients is expected to expand, enhancing clinical decision-making and reducing the necessity for liver biopsies.<\/jats:p>","DOI":"10.3390\/jcm14228164","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:55:31Z","timestamp":1763556931000},"page":"8164","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessing Liver Fibrosis in Chronic Hepatitis B: Liver Biopsy or Non-Invasive Fibrosis Markers?"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7769-4555","authenticated-orcid":false,"given":"Deniz","family":"Borcak","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, 34147 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7210-1084","authenticated-orcid":false,"given":"Zuhal","family":"Yesilbag","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Taksim Training and Research Hospital, 34433 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7428-5091","authenticated-orcid":false,"given":"Yusuf Emre","family":"Ozdemir","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, 34147 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6552-4751","authenticated-orcid":false,"given":"Adile Sevde","family":"Demir","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, 34147 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7595-6290","authenticated-orcid":false,"given":"Esra Salim","family":"Dogdas","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, 34147 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8920-9019","authenticated-orcid":false,"given":"Aysegul Inci","family":"Sezen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, 34147 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1465-3283","authenticated-orcid":false,"given":"Esra Canbolat","family":"Unlu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, 34147 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevtap","family":"Senoglu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, 34147 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7716-3006","authenticated-orcid":false,"given":"Hayat Kumbasar","family":"Karaosmanoglu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Taksim Training and Research Hospital, 34433 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2963-4894","authenticated-orcid":false,"given":"Kadriye Kart","family":"Yasar","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, 34147 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3350\/cmh.2022.0342","article-title":"Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection","volume":"29","author":"Lin","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.3350\/cmh.2024.0371","article-title":"Vibration-controlled transient elastography for significant fibrosis in treatment-na\u00efve chronic hepatitis B patients: A systematic review and meta-analysis","volume":"30","author":"Kim","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.4240\/wjgs.v15.i7.1388","article-title":"Major complications after ultrasound-guided liver biopsy: An annual audit of a Chinese tertiary-care teaching hospital","volume":"15","author":"Chai","year":"2023","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cgh.2010.03.025","article-title":"Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial","volume":"8","author":"Seeff","year":"2010","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1007\/s10620-021-07089-w","article-title":"Incidence of complications from percutaneous biopsy in chronic liver disease: A systematic review and meta-analysis","volume":"67","author":"Alkhouri","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.21037\/atm.2017.01.28","article-title":"Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection","volume":"5","author":"Parikh","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4274\/vhd.galenos.2023.2023-8-2","article-title":"Relationships between liver histopathology with biochemical parameters, and hepatitis B virus-DNA in chronic hepatitis B infection","volume":"29","author":"Borcak","year":"2023","journal-title":"Viral Hepat. J."},{"key":"ref_8","first-page":"1","article-title":"Comparison and value of non-invasive tests in chronic hepatitis B and C versus liver biopsy","volume":"65","author":"Demirdal","year":"2025","journal-title":"Haydarpasa Numune Med. J."},{"key":"ref_9","unstructured":"World Health Organization (2015). Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection, WHO. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789241549059."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(24)00437-0","article-title":"Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: A systematic review and meta-analysis","volume":"10","author":"Liguori","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Moosavy, S.H., Eftekhar, E., Davoodian, P., Nejatizadeh, A., Shadman, M., Zare, S., and Nazarnezhad, M.A. (2023). AST\/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran. BMC Gastroenterol., 23.","DOI":"10.1186\/s12876-023-02780-w"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2217\/bmm-2023-0405","article-title":"Performance of noninvasive fibrosis indices in chronic hepatitis B during pretreatment and post-treatment periods","volume":"17","author":"Ozdemir","year":"2023","journal-title":"Biomark. Med."},{"key":"ref_13","unstructured":"European Association for the Study of the Liver (2025). EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol., 83, 502\u2013583."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2893.1997.00141.x","article-title":"Age and platelet count: A simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus","volume":"4","author":"Poynard","year":"1997","journal-title":"J. Viral Hepat."},{"key":"ref_16","first-page":"226","article-title":"The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa","volume":"1","author":"Lemoine","year":"2016","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"ref_18","unstructured":"Social Security Institution of Turkey (2024). Communiqu\u00e9 on Amendment to the Health Implementation Communiqu\u00e9."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2021). EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u20142021 update. J. Hepatol., 75, 659\u2013689.","DOI":"10.1016\/j.jhep.2021.05.025"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/HEP.0000000000000845","article-title":"AASLD practice guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis","volume":"81","author":"Sterling","year":"2025","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-016-9760-3","article-title":"Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: A 2016 update","volume":"11","author":"Shiha","year":"2017","journal-title":"Hepatol. Int."},{"key":"ref_22","first-page":"62","article-title":"GPR, King\u2019s Score and S-Index are superior to other non-invasive fibrosis markers in predicting liver fibrosis in chronic hepatitis B patients","volume":"85","author":"Ekin","year":"2022","journal-title":"Acta Gastroenterol. Belg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/MEG.0000000000001381","article-title":"Diagnostic accuracy of \u03b3-glutamyl transpeptidase-to-platelet ratio for predicting hepatitis B-related fibrosis: A meta-analysis","volume":"31","author":"Lian","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/jvh.12842","article-title":"Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B","volume":"25","author":"Liu","year":"2018","journal-title":"J. Viral Hepat."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.3748\/wjg.v28.i27.3503","article-title":"Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China","volume":"28","author":"Liao","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.14218\/JCTH.2022.00098","article-title":"Advantages of a novel model for predicting hepatic fibrosis in chronic hepatitis B virus carriers compared with APRI and FIB-4 scores","volume":"10","author":"Kang","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_27","unstructured":"World Health Organization (2024). Guidelines for the Prevention, Diagnosis, Care and Treatment for People with Chronic Hepatitis B Infection, World Health Organization."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4274\/vhd.galenos.2023.2022-11-1","article-title":"Follow-up, Treatment and Non-invasive Scoring Systems in Chronic Hepatitis B: A Retrospective Observational Study","volume":"29","author":"Gezer","year":"2023","journal-title":"Viral Hepat. J."},{"key":"ref_29","first-page":"25","article-title":"Evaluation of fibrosis with noninvasive biochemical tests in chronic viral hepatitis B","volume":"4","author":"Kaya","year":"2023","journal-title":"Hepatol. Forum"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.14218\/JCTH.2021.00151","article-title":"Gamma-glutamyl transpeptidase to platelet ratio predicts liver injury in hepatitis B e antigen-negative chronic hepatitis B patients with normal alanine aminotransferase","volume":"10","author":"Zhao","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e9781","DOI":"10.1097\/MD.0000000000009781","article-title":"Assessment of liver fibrosis in Egyptian chronic hepatitis B patients: A comparative study including five noninvasive indexes","volume":"97","author":"Omar","year":"2018","journal-title":"Medicine"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Wang, J., Sun, X., Wei, S., Chen, X., Zhu, H., Liantang, Y., Bao, R., and Du, Y. (2024). Noninvasive models for the prediction of liver fibrosis in patients with chronic hepatitis B. BMC Gastroenterol., 24.","DOI":"10.1186\/s12876-024-03270-3"},{"key":"ref_33","first-page":"e60266","article-title":"Noninvasive models to predict liver fibrosis in patients with chronic hepatitis B: A study from Turkey","volume":"17","author":"Korkmaz","year":"2017","journal-title":"Hepat. Mon."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4274\/vhd.galenos.2020.2019.0038","article-title":"Diagnostic performance of non-invasive fibrosis indexes in hepatitis B related fibrosis","volume":"26","author":"Sayar","year":"2020","journal-title":"Viral Hepat. J."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Guo, S., Gan, L., Du, F., Feng, Q., Li, J., Wan, Q., Meng, Q., Zhang, Y., Ji, Y., and Liu, J. (2025). S index: A predictor comparable to ultrasound shear wave elastography in assessing liver fibrosis in patients with chronic hepatitis B. BMC Med. Imaging, 25.","DOI":"10.1186\/s12880-025-01846-3"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1874285801913010034","article-title":"Investigating the Efficiency of APRI, FIB-4, AAR and AARPRI as Noninvasive Markers for Predicting Hepatic Fibrosis in Chronic Hepatitis B Patients in Bangladesh","volume":"13","author":"Fazley","year":"2019","journal-title":"Open Microbiol. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.3748\/wjg.v23.i41.7425","article-title":"Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B","volume":"23","author":"Hu","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.medmal.2019.02.004","article-title":"A new combined predicting model using a non-invasive score for the assessment of liver fibrosis in patients presenting with chronic hepatitis B virus infection","volume":"49","author":"Koubaa","year":"2019","journal-title":"Med. Mal. Infect."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.5152\/tjg.2020.20139","article-title":"Diagnosis of liver fibrosis in patients with hepatitis B-related liver disease using ultrasound with wave-number domain attenuation coefficient","volume":"31","author":"He","year":"2020","journal-title":"Turk. J. Gastroenterol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/22\/8164\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:25:20Z","timestamp":1763558720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/22\/8164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":39,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["jcm14228164"],"URL":"https:\/\/doi.org\/10.3390\/jcm14228164","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]}}}